Bioprocess Bags Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, UK, China - Size and Forecast 2024-2028

Bioprocess Bags Market 2024-2028

The global bioprocess bags market size is estimated to grow by USD 4,173.2 million at a CAGR of 17.33% between 2023 and 2028. 

The rising demand for biopharmaceuticals stands as a primary driver shaping the global bioprocess bags market. Biopharmaceuticals, which contain a diverse range of therapeutic products emanating from living organisms, have witnessed unprecedented demand owing to their effectiveness in treating various medical conditions. Monoclonal antibodies, vaccines, gene therapies, and cell-based therapies are among the key products contributing to this surge in demand. Monoclonal antibodies, used for treating cancer, autoimmune diseases, and infectious diseases, have seen substantial growth. For instance, drugs such as Herceptin and Rituxan, which are monoclonal antibodies, have become important in cancer treatments. Furthermore, the versatility of bioprocess bags in accommodating the production of diverse biopharmaceuticals is pivotal in meeting the needs of the evolving healthcare landscape. Thus, such factors are expected to drive market growth during the forecast period.

Technavio has segmented the market into Method, End-user, and Geography 

• The method segment includes upstream process, downstream process, and process development
• The end-user segment includes pharmaceutical and biopharmaceutical companies, CMOs and CROs, and academic research institutes
• The geography segment includes key regions such as North America, Europe, Asia, and Rest of World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022 , besides analyzing the current market scenario.

What will be the Size of the Bioprocess Bags Market During the Forecast Period?

To learn more about this report, Download Report Sample

Bioprocess Bags Market Segmentation byMethod, End-user, and Geography Analysis

Method Analysis 

Upstream process

The market share growth by the upstream process segment will be significant during the forecast period.  Upstream processing plays a vital role in the primary stages of bioprocessing, affecting the cultivation and preparation of cells or microorganisms for subsequent biomanufacturing. The adoption of single-use technologies during this phase can significantly improve the overall process. The initial step, known as cell line development, entails the careful selection of an appropriate cell line tailored to produce the target biopharmaceutical product.

Get a glance at the market contribution of various segments Download PDF Sample

The upstream process segment was valued at USD 793.80 million in 2018. Subsequently, the chosen cell line undergoes cultivation in a bioreactor. This cultivation occurs under meticulously controlled conditions, including factors such as temperature, pH, and nutrient supply. The aim is to create an optimal environment that fosters both cell growth and the production of the desired proteins. Upon reaching the desired growth phase, the cultivated cells undergo harvesting. This critical step involves separating the cells from the culture media, marking a pivotal moment in the upstream processing of biopharmaceuticals. Thus, such factors will drive the growth of the market through the upstream process segment during the forecast period.

End-user Analysis

Pharmaceutical and biopharmaceutical companies

Pharmaceutical and biopharmaceutical companies represent a crucial segment within the global bioprocess bags market. These companies are at the forefront of developing, manufacturing and commercializing innovative therapeutic drugs, including biopharmaceuticals such as monoclonal antibodies, vaccines, and cell therapies. Throughout the biopharmaceutical production workflow, pharmaceutical and biopharmaceutical companies leverage bioprocess bags in both upstream and downstream processes. In the upstream phase, these bags facilitate the containment and sterile storage of cell culture media, growth factors, and other raw materials critical for cell expansion and fermentation. Furthermore, as pharmaceutical and biopharmaceutical companies continue to drive advancements in healthcare, the role of bioprocess bags remains pivotal in supporting their quest for groundbreaking therapies and treatments, which will thereby help the market in the pharmaceutical and biopharmaceutical segment to grow during the forecast period.

CMOs and CROs

Contract manufacturing organizations (CMOs) and contract research organizations (CROs) play a key role in the biopharmaceutical industry by offering outsourced services to pharmaceutical and biopharmaceutical companies. CMOs specialize in providing manufacturing services, while CROs focus on research and development activities. Both types of organizations depend on flexible and adaptable manufacturing solutions, with bioprocess bags emerging as key components to meet the diverse needs of their clients. CMOs leverage bioprocess bags to provide scalable and efficient manufacturing services for their clients. These bags offer a versatile solution that aligns with the demand for flexibility in production volumes and product types. CROs, on the other hand, utilize bioprocess bags to facilitate their research initiatives. Thus, such factors will drive the growth of the market in the CMOs and CROs segment during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The North American bioprocess bags market is experiencing steady growth, propelled by substantial investments in healthcare research and testing, particularly in the US. Robust distribution networks, coupled with the biopharmaceutical industry's focus on drug discovery and development, are key drivers in the region. The US, with its influential role, houses major biopharmaceutical manufacturers, fostering cutting-edge technologies. The collaborative efforts of renowned companies like Amgen Inc., Biogen Inc., and Genentech, Inc., contribute to North America's leadership. Additionally, the Canadian pharmaceutical industry's dedication to innovative R&D plays a vital role. The growing R&D activities in the pharmaceutical sector are expected to drive demand for bioprocessing solutions, fostering market growth. Market forecasting and analysis predict continued expansion, emphasizing the region's dynamic trends. 

Buy Full Report Now

Key Bioprocess Bags Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Avantor Inc: The company offers bioprocess bags such as VWR Single Use Bioprocessing bags.

• Beijing Bio Partner Biotechnology Co. Ltd.
• Bruckner Group SE
• CellBios Healthcare and Lifesciences Pvt. Ltd.
• Compagnie de Saint Gobain
• Corning Inc.
• Danaher Corp.
• Enpro Industries Inc.
• Entegris Inc.
• GE Healthcare Technologies Inc.
• ILC Dover LP
• Lonza Group Ltd.
• Meissner Filtration Products Inc.
• Merck KGaA
• Optimum Processing Inc.
• Parker Hannifin Corp.
• Repligen Corp.
• Sartorius AG
• Single Use Support GmbH
• Solida Biotech GmBH

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Bioprocess Bags Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. 

Key Bioprocess Bags Market Drivers

The growing shift toward single-use technologies in bioprocessing is the key factor driving market growth. The bioprocessing industry's trajectory has undergone a significant shift from traditional stainless-steel systems to the rising prominence of single-use technologies. This transformation, driven by the quest for heightened flexibility, cost-effectiveness, and reduced contamination risk, is well-reflected in the market growth analysis. Bioprocess bags, pivotal components in single-use systems, offer multifaceted advantages, streamlining cleaning processes, minimizing cross-contamination risks, and ensuring adaptability to dynamic production needs.

Moreover, key market players such as Thermo Fisher Scientific Inc, Sartorius AG, and GE Healthcare contribute significantly, shaping the market research and growth landscape. As the industry leans towards single-use technologies, collaboration among stakeholders becomes paramount, ensuring continuous innovation and efficiency. This collaborative effort is instrumental in market growth and forecasting, projecting sustained growth during the forecast period. 

Significant Bioprocess Bags Market Trends

Rising focus on the use of advanced materials bioprocess bags is one of the primary market trends shaping market growth. Manufacturers are continually exploring new materials that meet the stringent requirements of bioprocessing while addressing concerns related to purity, leachables, and overall product integrity. In recent years, there has been a shift towards the development of advanced polymeric materials with improved strength, durability, and flexibility. High-performance polymers, such as fluoropolymers, have gained traction due to their excellent chemical resistance and compatibility with a wide range of biopharmaceutical substances. These materials contribute to the prevention of leachables and extractables, ensuring the integrity of the bioprocess and the quality of the final product.

Additionally, the industry has seen innovations in multi-layer film technologies that combine different materials to achieve specific performance characteristics. Examples of advanced materials include high-density polyethylene (HDPE), polyethylene terephthalate (PET), and ethylene vinyl acetate (EVA), among others. These materials offer a balance of mechanical strength, chemical resistance, and flexibility. Moreover, efforts are being made to incorporate more sustainable materials into bioprocess bag manufacturing, aligning with the industry's commitment to environmental responsibility. Thus, such factors are expected to drive market growth during the forecast period.

Major Bioprocess Bags Market Challenges

Several complexities associated with bioprocessing is a challenge that affects market growth. Bioprocessing involves a series of intricate steps for the production of biopharmaceuticals, including cell culture, fermentation, purification, and final formulation. Incorporating bioprocess bags into this multifaceted workflow needs detailed planning and validation to ensure compatibility with diverse manufacturing processes. One aspect of complexity arises from the variability in biopharmaceutical production. Different therapeutic products may demand unique conditions like specific temperatures, pH levels, and nutrient requirements during cell culture.

Furthermore, the intricate nature of bioprocessing also involves the challenge of achieving seamless integration of bioprocess bags into existing manufacturing facilities. This integration requires validation processes to demonstrate that the disposable systems do not compromise product quality, safety, or regulatory compliance. Hence, the different complexities associated with bioprocessing may impede the growth of the market during the forecast period.

Buy Now Full Report

Key Bioprocess Bags Market Customer Landscape

The market analysis and report includes the adoption lifecycle of the market trends and analysis, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Bioprocess Bags Market Customer Landscape

Segment Overview

The bioprocess bags market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest market growth and trends opportunities from 2018 to 2028. 

• Method Outlook
  • Upstream process
  • Downstream process
  • Process development

• End-user Outlook
  • Pharmaceutical and biopharmaceutical companies
  • CMOs and CROs
  • Academic research institutes

• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of World (ROW)
    • Brazil
    • Australia
    • Argentina

Bioprocess Bags Market Scope
Report Coverage	Details
Page number	177
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 17.33%
Market Growth 2024-2028	USD 4,173.2 million
Market structure	Fragmented
YoY growth 2023-2024(%)	16.07
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 35%
Key countries	US, Germany, France, UK, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Avantor Inc., Beijing Bio Partner Biotechnology Co. Ltd., Bruckner Group SE,  CellBios Healthcare and Lifesciences Pvt. Ltd., Compagnie de Saint Gobain, Corning Inc., Danaher Corp., Enpro Industries Inc., Entegris Inc., ESI Technologies Ltd., GE Healthcare Technologies Inc., ILC Dover LP, Lonza Group Ltd., Meissner Filtration Products Inc., Merck KGaA, Optimum Processing Inc., Parker Hannifin Corp., Repligen Corp., Sartorius AG, Single Use Support GmbH, Solida Biotech GmBH, TECNIC PROCESS EQUIPMENT MANUFACTURING SLU, and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Bioprocess Bags Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the bioprocess bags market forecast between 2024 and 2028
• Precise estimation of the bioprocess bags market size and its contribution to the market in focus on the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies' position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of bioprocess bags market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch